Nicotine & Cannabis Strategies 2020 - A Virtual Experience

Biography:

Session Details: View In Agenda

Biography:

Session Details: View In Agenda

Biography: Nathan Mison is the Vice President of Government and Stakeholder Relations at Fire & Flower. Prior to joining Fire & Flower, Mr. Mison was the Principal of Mison & Associates, a national consulting firm that focuses on government relations, stakeholder consultation and executive counsel. Nathan is the co-chair of the National Cannabis Working Group for the Canadian Chamber of Commerce, the Chair of the Alberta Cannabis Council. founding member of NorthCanvas, an ancillary cannabis incubator, a member of the Alberta Cannabis Stakeholder Group and a founding member of the Alberta Cannabis Retailers Association. Nathan volunteers his time as the President of the Valley Zoo Development Society and is the co-founder of Politics on Tap. He has been married to Stacey for 16 years and has 3 incredible children.

Session Details: Discussing Strategies For Eliminating The “Black Or Illicit” Market In Order To Achieve Effective And Consistent Growth Of Companies 15-06-2020, 10:00 am View In Agenda

Biography:

Session Details: Overcoming The THC Limits On Edibles, Extracts and Topicals In Order To Market Sufficient Quality Products That Are Easy To Consume 16-06-2020, 11:15 am View In Agenda

Biography: Terry is the Chairman & CEO of Hill Street Beverage Co., focused on the production of world class, award winning cannabis-infused and alcohol-free wine and beer. Hill Street’s alcohol free products are currently available in thousands of leading grocery and drug stores across Canada. Their products have won awards around the world, including three Golds at the US Open Beer championships, a Double Gold at the San Francisco International Wine Challenge, and the Retail Council of Canada’s Grand Prix Award. The company is listed on the Toronto Stock Exchange with the ticker symbol BEER, which he thinks is both hilarious and awesome. The company is preparing its brewing and winemaking operations to become a leader in cannabis infused beverages to be available in 2020 or whenever the government approves them. Terry is also the co-founder of the Cannabis Beverage Producers Alliance, a national organization representing the unique interests of beverage producers for lobbying and public education.

Session Details: Case Study: Understanding How To Launch Cannabis Beverages Into The Market In Order To Achieve Successful Market Expansion 15-06-2020, 11:10 am View In Agenda

Biography:

Session Details: CBD Enters Luxury: Providing A Lesson in Brand Building To Understand How To Effectively Market Luxury Consumer Products 15-06-2020, 9:00 am View In Agenda

Biography: Paul Gurney is a Managing Director at BMO Capital Markets in London, UK, leading BMO’s coverage of large institutional equity clients in Europe and Asia Pacific. Paul has 15 years of capital markets experience, researching companies, syndicating transactions, structuring deals, and providing value-added advice to institutional and corporate clients across multiple sectors. In early 2018, Bank of Montreal (BMO) became the first major bank to underwrite the cannabis sector, leading a US$175m equity financing for the world’s largest cannabis company, Canopy Growth. Paul has been closely involved in the sector in Europe ever since, helping raise US$153m for Tilray, the first ever NASDAQ listed cannabis company, and the third best performing IPO in the US in 2018. Paul spearheads BMO’s investment efforts for cannabis companies in Europe, and Australia, introducing investors to sector heavyweights like Aphria, Aurora, Canopy Growth and Tilray, while actively developing the next generation of pre-IPO cannabis companies. Paul’s early involvement in the sector has helped him develop a deep network of industry and client contacts, making him one of the thought leaders for the sector in Europe.

Session Details: Addressing The Need For Key Investors And Involvement Of Banks In Order To Maximize The Profitability Of Companies 16-06-2020, 10:45 am View In Agenda

Biography:

Session Details: WELLNESS SPOTLIGHT Next-gen cannabis products: Customised cannabinoid formulations for targeted results 15-06-2020, 1:25 pm View In Agenda

Biography:

Session Details: Cannabinoid Therapy 16-06-2020, 1:00 pm View In Agenda

Biography: Matthew Jason Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion for creating strategic alliances. He brings breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University of Texas at Austin, while playing football for the Texas Longhorns football team.  As a quarterback on a National Championship winning team, he developed skills that would be carried through his lifetime and core business philosophies. While playing football on scholarship for The University of Texas, he was able to graduate with two degrees in less than four years and was accepted into and pursued a dual master’s degree program at the University of Dallas. After playing professionally briefly with the Detroit Lions and Philadelphia Eagles, Mr. Nordgren went on to earn two additional master’s degrees in both business and sports management from the University of Dallas. He was subsequently featured on the Bravo TV show “Most Eligible Dallas,” while becoming a partner in the family business, NORDCO, Inc., a Dallas-based energy firm.  This is also when he helped to develop, manage and build his first private equity/family office business with a sports and media focus which lead to a career in running various investment vehicles across a broad spectrum of strategies. Throughout his career, Mr. Nordgren has been appointed to many executive leadership positions at a wide-ranging group of companies and industries. From real estate to sports and entertainment, from hospitality to insurance and financial services, from emerging industries to later stage leveraged buy outs, he is singularly focused on finding synergistic opportunities in early stage private growth rounds that have upside potential.  He is committed to successfully helping manage the overall financial state of his partners businesses and the companies with which he and his partners have interests within. Mr. Nordgren is currently CEO and Founder of ARCADIAN Fund and ARCADIAN Capital Management, a venture fund/private equity strategy focused on the ancillary service providing companies in and around the cannabis and hemp industries.  More specifically, on Series A/B type opportunities where proven businesses are looking for growth equity to continue scaling into new markets.  He was recently name one of the “Top 100 Most Influential People in the Cannabis Industry” by High Times Magazine and ranked number 3 globally by Business Insider in terms of investment companies focused on the emerging cannabis and hemp sectors. Additionally, he is the founder of Nordco Consulting LLC, a private consulting firm dedicated to the business development of middle market companies with forward-thinking vision. To date, Mr. Nordgren has personally been involved with over $7 billion in transactions and maintains a portfolio of approximately 30 plus companies.

Session Details: Analyzing banking and finance options in the cannabis industry 15-06-2020, 12:55 pm View In Agenda

Biography:

Session Details: Building your brand and public awareness to send out the right message – communication is key 16-06-2020, 1:30 pm View In Agenda

Biography: James Schwartz BSN, LNC, is an experienced medical legal consultant and CEO of CascadeHigh Organics with 20years experience cultivating legal cannabis. James is a self-described organic minimalist cultivating in the most sustainable manner. James believes in clean Cannabis and its use as a wellness drug. His Oregon licensed cultivation has been featured in Dope Magazine, Oregon Leaf Magazine, and has articles in both publications as well.  James is currently on the NCIA Cultivation Committee and has presented at multiple Cannabis and CBD conferences all over the country.  James was a drafter and is a signature on the written testimony to the FDA and congress on behalf of NCIA for CBD policy.  His business, legal, medical, and agricultural knowledge provides a comprehensive perspective on the cannabis industry. James has lobbied for Cannabis on both the national and state level with Oregon Cannabis Association and is a fierce advocate for the plant and cannabis therapeutics

Session Details: Regulation update: an overview of the current legal landscape in the US 15-06-2020, 11:40 am View In Agenda

Biography: BRET ACKERMAN, PRESIDENT, CAPITAL MARKETS, Over 20 years of combined structured finance and structured products trading experience. Bret has held positions in investment origination, structuring, and securitization. Bret’s career began at Bear Stearns in 1997 where he as Vice President, jointly responsible for a 12+ billion USD portfolio of firm-managed assets. In 2006, Bret joined Barclays Capital as the Head of Non-Agency/RMBS Securitization, when he was responsible for establishing and managing their 8+ billion USD Private Label/Non- Agency securitization business. During this time, Bret was named “Top 30 Traders Under 30 Years Old” by Trader Monthly Magazine. Bret was subsequently Managing Director at MF Global, Head of RMBS Trading at StormHarbour Securities, and most recently, Head of RMBS Sales and Trading at Odeon Capital Group.  In the cannabis and hemp marketplaces, Bret focused on sourcing and analyzing market dynamics, individual businesses and macro and micro opportunities.

Session Details: Demystifying the cannabis industry: An overview of the evolving nature of the landscape 15-06-2020, 12:10 pm View In Agenda

Biography: Travis Priddy is the founder and CEO of 369 Hemp, a startup hemp cigarette company located in Ridgeway, SC’s Opportunity Zone.  Travis is a seasoned entrepreneur; in 2017 he sold his previous cannabis startup, GreenRock Botanicals, Inc., of California, to a well known publicly traded company.  In 2014, after a 12 year career at Philip Morris International managing multiple international cigarette markets for the tobacco giant, Travis started his first company, Rock Vapor Technologies, Inc, which designed and manufactured electronic cigarettes in Austin, TX and San Clemente, California.  Travis currently resides in Greenville, SC with his wife and 3 sons.  When he is not working on his new manufacturing project with the 369 Hemp team, he can be found on the sidelines or in the dugout at one of his son’s (many) games as coach or enthusiastic supporter

Session Details: Product innovation: overview of new products in the nicotadaine market 15-06-2020, 10:00 am View In Agenda

Biography:

Session Details: The politics behind the Trump flavor ban: where we go from here 15-06-2020, 9:00 am View In Agenda

Biography: Since he was young Charlie has had a passion for medicine and people. During the summers while in undergrad he would work as an EMT at a summer camp serving both children and adults with special needs. Through these life-changing experiences, he knew he had to purse his passion for medicine. He continued his education and graduated with a Master’s degree in Physiology and he was able to publish his thesis paper in the American Journal of Physiology- heart and Circulatory Physiology. He then attended Touro University of California where he completed a dual Master’s of Science in Physician Assistant Science (MSPAS) and Public Health (MPH). He moved back to Arizona where he practiced family medicine and then moved into pain management. He also is the founder and CEO of Restorative Care of Arizona, which is a patient centric wellness clinic in Phoenix, Arizona. Where they specialize in personalized medicine and taking care of the whole patient. After seeing many of his pain patients achieve great results with CBD, but some of them having THC in their drug screenings- he started to research CBD and the ECS. After a few years of research and successfully treating many patients, he has started his own CBD company to ensure the quality of product that his patients receive. Throughout his journey both before medicine and while practicing medicine he has added different tools and experiences that allow him to give his patients the best care possible. He understands that each patient is different and has their own unique journey of their health care and will require personalized treatments. He understands for a patient to be truly healthy, both their physical and psychological health has to be optimized. He can be reached at CPiermarini@rcofaz.com or at his office in Phoenix, Az. He welcomes any discussions surrounding CBD and looks forward to pushing this industry in the right direction.

Session Details: Medical Advisement: How can it help your company 16-06-2020, 10:00 am Medical Advisement: How can it help your company 16-06-2020, 10:00 am View In Agenda

Biography:

Session Details: Building a CBD consumer products brand: The Botanic Lab story 16-06-2020, 9:30 am View In Agenda

Biography:

Session Details: View In Agenda

Biography: ​

Session Details: The Swedish political experience – from glacial stalemate to facing the facts 16-06-2020, 9:00 am View In Agenda

Biography: Dr. Setnik has been working in the area of clinical drug development and abuse potential (AP) assessment since 2005.  Dr. Setnik is currently the Chief Scientific Officer at Altasciences and an Adjunct Professor at the University of Toronto (Department of Pharmacology and Toxicology).  Dr. Setnik earned her doctorate degree in Pharmacology and the Collaborative Program in Neuroscience from the University of Toronto in 2005.  In her former role as Vice President of Scientific & Medical Affairs at INC Research/inVentiv Health (Early Phase), she was responsible for scientific input on early phase clinical trials and in strategic initiatives in business growth and development.  In her previous role as Senior Director, Clinical Sciences (King Pharmaceuticals and Pfizer, Inc), Dr. Setnik lead the clinical development, regulatory filing, and lifecycle management, including abuse potential evaluation, of several pain compounds including abuse deterrent opioid formulations. In her previous role as a Research Scientist (formerly Ventana / Decisionline Clinical Research, Toronto, Canada), Dr. Setnik was responsible for providing scientific input on various specialty phase I-II clinical trials including abuse potential studies for CNS drugs.   Dr. Setnik has published numerous research articles in internationally recognized peer-reviewed journals and has presented at over 200 scientific meetings and conferences.  In addition, she is the Managing Director and Clinical subgroup lead Cross Company Abuse Liability Council and chair of the Clinical Pharmacology Community of the Drug Information Association (DIA). Dr. Setnik is also an active member and participant in several congresses including the College on Problems of Drug Dependence. She has also been actively engaged in many aspects of abuse potential assessment including development of patient reported outcome instruments and contributing to post-marketing surveillance studies.

Session Details: Clinical Trials with Tobacco Products: Examining Abuse Potential, Exposure, and Biomarkers 15-06-2020, 12:55 pm Navigating the highs and lows of clinical trials with cannabis 16-06-2020, 12:30 pm View In Agenda

Biography:

Session Details: Identifying The Next Hot Opportunity For Growth In Cannabis To Highlight Future Market Trends 15-06-2020, 10:30 am View In Agenda

Biography:

Session Details: View In Agenda

Biography:

Session Details: View In Agenda

Biography:

Session Details: What's next in cannabis? 16-06-2020, 9:00 am View In Agenda

Biography:

Session Details: Welcome address and chair’s opening remarks 15-06-2020, 8:50 am Welcome address and chair’s opening remarks 15-06-2020, 8:50 am View In Agenda

Biography:

Session Details: View In Agenda

Biography:

Session Details: Safety Evaluation of Extractables and Leachables for E-Cigarette Devices 15-06-2020, 10:30 am View In Agenda

Biography:

Session Details: What's next in cannabis? 16-06-2020, 9:00 am View In Agenda

Biography:

Session Details: Understanding Recent Scientific Developments In Order To Promote Healthy And Safe Consumption Of Cannabis 16-06-2020, 11:45 am View In Agenda

Biography:

Session Details: Combating Youth Use: are flavors to blame for the increased use in youths? 16-06-2020, 10:45 am View In Agenda

Biography:

Session Details: DREAM: Why we decided to go for the PMTA Step-by-step guide on the PMTA guidelines and how your company can meet the requirements 15-06-2020, 11:10 am View In Agenda

Biography:

Session Details: View In Agenda

Biography: Joe, an experienced litigator, is an associate in Thompson Hine’s Business Litigation practice group. Joe counsels clients with respect to federal and state regulation related to the cannabis industry, including marijuana, hemp, and CBD products. Clients have included businesses and individuals directly in the industry as well as businesses working alongside and with the industry, including retailers, packagers, and equipment, parts, and ingredient suppliers. Joe has advised clients on regulatory compliance as well as potential challenges and defenses to state and federal laws and regulations, and responding to regulatory agencies such as the FDA. In addition to his work with the cannabis industry, Joe represents clients in state and federal courts in a broad range of commercial and civil matters including challenges to state and federal laws, patent and trademark litigation, contractual disputes, and product liability claims.

Session Details: Legal Challenges & Risks in an Unsettled Regulatory Landscape 15-06-2020, 9:30 am View In Agenda

Biography: Eric N. Heyer is a partner in Thompson Hine LLP's Washington, D.C. office and leads the firm's vaping industry practice.  Eric was integrally involved in the first federal lawsuit in 2009 that successfully challenged FDA's categorization of ENDS products as unapproved new drugs or medical devices. Over the years, Eric has counseled and represented both foreign and domestic ENDS device and e-liquid manufacturers, wholesalers, distributors, and retailers on all manner of federal and state regulatory compliance issues, on the preparation of pre-market tobacco applications (PMTAs), in significant transactions, and in litigation, including Proposition 65 litigation, patent and trademark litigation, contractual disputes, product liability claims, a constitutional case that successfully challenged Indiana’s statutory scheme regulating the manufacture of e-liquids, and the case that resulted in an injunction against New York’s emergency flavor ban in 2019.

Session Details: The Delicate Balance: Effective ENDS Marketing Strategies that are “Appropriate for the Protection of the Public Health” in the Age of Cutthroat Competition and PMTAs 15-06-2020, 1:25 pm View In Agenda

Biography: Bruce is the CEO of Electric Tobacconist and has been since the inception of the company in 2015. Originally from the UK but having lived in the US since 2007 Bruce is located in Boulder, Colorado, where the Electric Tobacconist and all staff are based.

Session Details: Direct to consumer: how online businesses are surviving in a highly regulated environment 16-06-2020, 11:15 am View In Agenda

Biography:

Session Details: View In Agenda

Biography:

Session Details: Cost Effective Approach to PMTA 16-06-2020, 11:45 am View In Agenda

Biography:

Session Details: Nicotine Supply Chain 15-06-2020, 12:10 pm PMTA Submission Process 16-06-2020, 9:30 am View In Agenda

Biography:

Session Details: Pointers and Pitfalls of PMTA Perceptions Research 15-06-2020, 11:40 am View In Agenda

Biography:

Session Details: Do E-liquid Flavors Affect the Production of HPHCs: Potential Impacts for Bridging Studies 15-06-2020, 9:30 am View In Agenda

Biography: Mark has a Master’s degree in Chemical Engineering and an MBA. Prior to joining Nicobrand in 2001, he gained valuable experience in pharmaceuticals and nutritionals with Abbott Laboratories. At Nicobrand Mark has been instrumental in the scale-up and development of their nicotine active ingredients products, initially for the nicotine replacement sector and more recently for the Next Generation product category. Within the past 12 months Nicobrand has become part of Contraf-Nicotex-Tobacco (CNT), its long time peers in the nicotine business, leading to the creation of a combined entity with an unrivalled wealth of experience and knowledge in nicotine and product development.

Session Details: Nicotine Supply Chain 15-06-2020, 12:10 pm View In Agenda